#110 - Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K

May 11, 2020 Episode Page ↗
Overview

Lew Cantley, Professor of cancer biology at Weill Cornell, discusses his discovery of PI3K, the metabolic nature of cancer, and the link between sugar, insulin resistance, and tumor growth. He also explores how prescriptive nutritional therapies can enhance cancer drug efficacy.

At a Glance
34 Insights
2h 11m Duration
15 Topics
6 Concepts

Deep Dive Analysis

Introduction to Lou Cantley and PI3K Discovery

Teaching Science Through the Lens of Discovery

The Metabolic Nature of Cancer and the Warburg Effect

Personal Observation Leading to Sugar Restriction

Connection Between Obesity, Insulin Resistance, and Cancer

Sugar Consumption and Colorectal Tumor Growth Research

Impact of Natural Sugar vs. HFCS and Fruit vs. Juice

Increasing Efficacy of PI3K Inhibitors with Metabolic Therapies

Clinical Trial for Stage 4 Breast and Endometrial Cancer

The Future of Cancer Treatment: Diet-Drug Pairing

PI3K Inhibitors on the Market and Food Prescriptions

Lou Cantley's Future Research Focus

Early Work: Studying ATP Synthesis in Mitochondria

Discovery of PI3K: Insulin Signaling and SARC Oncogene

Unlikely Observation: Phosphorylation at the 3' Position

Discovery-based Science Education

This approach advocates for teaching science by narrating stories of scientific breakthroughs, emphasizing the process of inquiry, critical thinking, serendipity, and the challenges faced by scientists, rather than focusing on rote memorization of facts.

Warburg Effect

Cancer cells exhibit significantly increased glucose uptake and metabolism, diverting glycolytic intermediates into anabolic processes for rapid growth, even when oxygen is available for more efficient mitochondrial ATP production. This challenges the initial assumption that cancer cells have defective mitochondria.

Insulin Resistance

A condition where cells in the liver, muscle, and fat fail to respond adequately to insulin, prompting the pancreas to produce higher levels of insulin to maintain normal blood glucose. This hyperinsulinemia, rather than obesity itself, is strongly linked to accelerated tumor growth.

PI3 Kinase (PI3K)

Phosphoinositide 3-kinase is an enzyme that phosphorylates the 3-position of the inositol ring on a lipid. This enzyme is crucial for mediating normal insulin signaling and is frequently activated by oncogenes, thereby driving cell growth in various cancers.

Fructose's Role in Colorectal Cancer

When consumed in liquid form alongside glucose, fructose can reach the colon and be converted to fructose 1-phosphate by ketohexokinase. This process depletes cellular ATP, allowing glucose to be shunted into anabolic pathways at an accelerated rate, directly fueling tumor growth.

Diet-Drug Pairing

A therapeutic strategy that combines specific dietary interventions, such as ketogenic diets or amino acid restriction, with pharmaceutical drugs to enhance the drug's efficacy, mitigate side effects, and improve overall cancer treatment outcomes.

?
How should science be taught to foster interest and understanding?

Science should be taught through the lens of discovery, focusing on the process, thinking, serendipity, and the stories of how scientists fumbled their way to breakthroughs, rather than through rote memorization of facts.

?
What is the metabolic nature of cancer, and how does it relate to the Warburg Effect?

Cancer cells exhibit a high rate of glucose uptake and metabolism (Warburg Effect), not necessarily because their mitochondria are defective, but because they divert glycolytic intermediates into anabolic processes to support rapid growth and cell division.

?
What is the connection between obesity, insulin resistance, and cancer?

High levels of insulin, often resulting from insulin resistance associated with obesity, can drive the growth of cancer cells, especially those that have increased expression of the insulin receptor.

?
How does sugar consumption, particularly fructose and glucose mixtures, promote tumor growth?

In colorectal cancer, a liquid mixture of fructose and glucose can reach the colon. Fructose is converted to fructose 1-phosphate, rapidly dropping cellular ATP levels, which in turn allows glucose to flux at a higher rate into anabolic pathways, directly feeding tumor growth.

?
What are the challenges of using PI3K inhibitors for cancer treatment, and how can they be overcome?

PI3K inhibitors can cause severe hyperglycemia, leading to high insulin levels that can reactivate PI3K in tumors, negating the drug's effect. This can be managed by avoiding insulin or insulin secretagogues, and instead using metformin, SGLT2 inhibitors, or a ketogenic diet to lower glucose and insulin levels.

?
Why is there confusion regarding 'natural sugar' versus high-fructose corn syrup?

Experimentally, there's no significant difference in the effect of sucrose (natural sugar) versus high-fructose corn syrup on tumor growth. The critical factor is whether the sugar is consumed in a liquid form, allowing it to reach the colon, or embedded in fibrous fruit, which slows absorption and prevents spikes in glucose and insulin.

?
What is the significance of the 3' position phosphorylation in inositol?

The discovery of phosphoinositide 3-kinase (PI3K) revealed that phosphorylation at the 3' position of the inositol ring creates new lipid species (PI3P, PI3,4P2, PI3,4,5P3) that are crucial for insulin signaling and oncogenic activation, mediating cell growth and other biological processes.

1. Prevent Insulin Resistance

Being in a state of insulin resistance can accelerate tumor growth in humans, highlighting the importance of metabolic health in cancer prevention and management.

2. Keep Insulin Levels Low

The ideal metabolic situation is to prevent insulin levels from getting high, as this can have detrimental effects on health, including accelerating tumor growth.

3. Prioritize Insulin Sensitivity

Focus on maintaining insulin sensitivity rather than just body mass index (BMI) for cancer risk, as insulin-resistant individuals (whether overweight or lean) show increased cancer risk.

4. Eliminate Sweet Drinks, Desserts

Based on empirical observation of the link between increased sugar consumption and obesity, eliminate sweet drinks and desserts from your diet.

5. Avoid Sugary Liquids

Consuming sugar in liquid form allows fructose to reach the colon, directly feeding polyp growth, whereas the same amount in solid food would be absorbed before reaching the colon.

6. Avoid Fructose-Glucose Mix

Colorectal polyps grow faster when both fructose and glucose are consumed together, with fructose driving the kinetics and glucose providing the carbon atoms for growth.

7. Reduce Sugar for Colon Health

High sugar consumption can significantly accelerate the growth and aggressiveness of colorectal polyps, even without causing obesity or insulin resistance, suggesting a direct feeding mechanism for tumor growth.

8. Beware Glucose-Fructose Combination

The natural combination of glucose and fructose, especially in liquid form, is uniquely problematic for health due to its chronic toxicity and ability to drive specific cancer growth.

9. Choose Whole Fruit Over Juice

The key difference in sugar consumption is whether it’s embedded in fibrous whole fruit (like an apple) or pure in water (like apple juice), as whole fruit slows absorption and prevents glucose spikes.

10. Eat Whole Fruit, Avoid Spikes

Eating whole fruit leads to slower sugar absorption and minimal glucose spikes, unlike fruit juice which causes rapid spikes, thus preventing high insulin release.

11. Manage Insulin Levels

When considering metabolic health, prioritize managing insulin levels, as high insulin is a key concern, even if glucose levels appear to be in line.

12. Recognize Insulin’s Cancer Role

Understand that high levels of insulin can drive the growth of cancer cells, a phenomenon observed in cell cultures for decades.

13. Pair PI3K Inhibitors with Diet/Drug

To maximize the efficacy of PI3 kinase inhibitors in shrinking tumors, combine them with either an SGLT2 inhibitor or a ketogenic diet (8% slow-release carb, 80% fat, 12% protein), as both dramatically lower insulin.

14. Ketogenic Diet or SGLT2

If you have cancer and are on a PI3 kinase inhibitor, a ketogenic diet is recommended for its effectiveness, but an SGLT2 inhibitor is a good, easier-to-take second-best option.

15. Ketogenic Diet Pre-Load

For optimal effectiveness when using a ketogenic diet with PI3 kinase inhibitors, begin the diet a full week prior to starting the inhibitor to deplete glycogen stores.

16. Combine KD with PI3K for Pancreatic Cancer

For pancreatic cancer (especially KRAS, P53 mutant types), a ketogenic diet alone or a PI3 kinase inhibitor alone may not be effective, but their combination can lead to complete tumor disappearance.

17. Avoid Insulin with PI3K Inhibitors

If undergoing cancer treatment with a PI3 kinase inhibitor and experiencing hyperglycemia, avoid insulin or insulin secretagogues, as these can raise serum insulin and reactivate tumor growth.

18. Metformin for Hyperglycemia

For patients on PI3 kinase inhibitors, metformin is the preferred method for managing hyperglycemia; if it’s insufficient, other insulin-raising treatments should be avoided.

19. Consider SGLT2 Inhibitors

SGLT2 inhibitors, which cause glucose to be excreted in the urine, are an effective way to lower both glucose and insulin levels.

20. Low-Carb Breakfast with PI3K Inhibitors

When taking PI3 kinase inhibitors, eat a low-carbohydrate, high-fat breakfast (e.g., scrambled eggs, avocado, high-fat yogurt with almonds) to limit toxicities, increase absorption, and avoid sugary items like juice or Ensure.

21. Maintain Strict Low-Carb Diet

To maximize the benefits of insulin-management strategies in cancer therapy, maintain a strict low-carbohydrate diet throughout the day, as even evening high-glucose meals can impact morning glucose and insulin levels.

22. Ketogenic Diet for Cancer: Supervise

Do not automatically adopt a ketogenic diet for cancer without medical supervision, as it may have adverse effects in certain cancer types (e.g., AML), even though it’s generally healthy for normal individuals.

23. Assess Tumor Insulin Receptors

Measuring insulin receptor levels on a tumor can help customize cancer therapy, as high levels may indicate a favorable response to approaches that manage insulin.

24. Restrict Serine/Methionine

For certain cancers and mutational backgrounds, restricting amino acids like serine or methionine in the diet can make specific drugs more effective by selectively depriving cancer cells of nucleotide precursors.

25. Embrace Diet-Drug Pairing

Recognize that combining specific dietary interventions with targeted drug therapies represents a significant and innovative frontier in cancer treatment.

26. Explore Pharmaceuticalized Diets

Consider pharmaceuticalized dietary interventions, such as precisely prepared meals with specific compositions, as a viable adjunct therapy for cancer patients to ensure adherence and optimize outcomes.

27. Oncologists Learn Cancer Metabolism

To improve cancer care, oncologists should deepen their understanding of cancer metabolism to effectively manage predictable complications of certain medications, such as hyperinsulinemia and hyperglycemia, which are desired features when using these drugs correctly.

28. Translate Science to Practice

Strive to translate scientific observations from the laboratory into practical changes in behavior, medical practice, drug metabolism, and diet to effectively address diseases like diabetes and cancer.

29. Investigate Unexpected Results

In scientific research, when you encounter an unexpected result, focus intensely on understanding the biochemical and chemical reasons behind it, as this is often where breakthroughs occur.

30. Embrace Confusing Results

When a result doesn’t make sense, view it as an exciting opportunity, as it often indicates a more complex underlying mechanism and can lead to significant breakthroughs if investigated thoroughly.

31. Teach Science via Discovery

When teaching science, focus on the process of discovery, the stories of experiments, and the thinking involved, rather than rote memorization of facts, to better engage and screen for interested scientists.

32. Advocate Anti-Sugar Policies

To combat high sugar consumption, consider public health strategies similar to those used for tobacco, such as reducing advertisements for sugary foods (especially to children) and implementing taxes to make sugar more expensive.

33. Explore Cancer Clinical Trials

If you or someone you know has stage four breast or endometrial cancer, look for enrollment information for the upcoming PI3 kinase alpha inhibitor trial from Petra Pharmaceuticals, which will be registered on clinicaltrials.gov.

34. Consult Your Physician

Always discuss combinations of therapies, including drugs for diabetes, cancer, and nutritional therapies, with your physician, as the podcast does not provide medical advice.

Serendipity in science is absolutely critical that when you get a result that's unexpected, you should be laser focused on understanding at the biochemistry, at the chemical level, why you got the different results than you expected to get.

Lou Cantley

If I get a result that suddenly doesn't make sense to me, that's more exciting. It means there's something more complicated going on than the simplest explanation for what I'm seeing.

Lou Cantley

I hated biology because at that time, at least in the backwoods of West Virginia where I was growing up, biology was just a bunch of descriptive memorization.

Lou Cantley

If you wanted to create a molecule to kill people, it's not just glucose. It's not even just fructose. It's put the two together. And guess what? Nature did that.

Peter Attia

The carbon atoms are coming from the glucose. The fructose is basically driving the kinetics.

Lou Cantley

Most endocrinologists worry about the glucose. I worry about the insulin.

Lou Cantley

If you put up a porous dam because a complete dam would kill the patient. Exactly. And insulin is tougher, and in the end it's going to win.

Peter Attia
10 to 50 fold
Increase in glycolysis rate in cancer cells Compared to the tissue of origin prior to transformation
1921
Approximate year of Warburg Effect publication Almost 100 years ago from the time of the podcast
Mid-1970s
Approximate year of insulin receptor purification When labs began purifying the insulin receptor
1978
Approximate year SARC oncogene was shown to be a protein kinase Discovery by Harold Varmus's lab
1989
Year Harold Varmus and Michael Bishop won Nobel Prize for SARC discovery Prize awarded for discovery of oncogenes
10 to 30 nanograms per mil
Serum insulin level after PI3K inhibitor administration Measured within 15 to 90 minutes in patients
8%
Carbohydrate percentage in mouse model ketogenic diet Slow release carbohydrate
80%
Fat percentage in mouse model ketogenic diet Rest of the diet composition
12%
Protein percentage in mouse model ketogenic diet Rest of the diet composition
100 millimolar
KM (Michaelis constant) for glycerol phosphorylation by SARC Enormous concentration, not physiologically relevant
5 micromolar
KM (Michaelis constant) for phosphatidyl inositol phosphorylation by PI3K Much lower concentration, indicating higher affinity
1 millimeter
Difference in migration of phosphorylated inositol species on thin layer Observed difference in spot migration between type 1 and type 2 PI kinase products
1988
Year of PI3K discovery paper publication in Nature Paper describing the discovery of phosphoinositide 3-kinase